Dr Kim Agnew, principal investigator of the Monepantel (MPL) trial, discusses the successes the drug is having in treating canine cancer.
Pet Industry News is Australia and New Zealand’s leading news service for the pet industry.
Dr Kim Agnew, principal investigator of the Monepantel (MPL) trial, discusses the successes the drug is having in treating canine cancer.